These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink. Furuland H, McEwan P, Evans M, Linde C, Ayoubkhani D, Bakhai A, Palaka E, Bennett H, Qin L. BMC Nephrol; 2018 Aug 22; 19(1):211. PubMed ID: 30134846 [Abstract] [Full Text] [Related]
7. Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study. Korgaonkar S, Tilea A, Gillespie BW, Kiser M, Eisele G, Finkelstein F, Kotanko P, Pitt B, Saran R. Clin J Am Soc Nephrol; 2010 May 22; 5(5):762-9. PubMed ID: 20203167 [Abstract] [Full Text] [Related]
9. Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population. Kieneker LM, Eisenga MF, Joosten MM, de Boer RA, Gansevoort RT, Kootstra-Ros JE, Navis G, Bakker SJ. PLoS One; 2017 May 22; 12(3):e0174686. PubMed ID: 28346526 [Abstract] [Full Text] [Related]
15. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial. Heerspink HJ, Gao P, de Zeeuw D, Clase C, Dagenais GR, Sleight P, Lonn E, Teo KT, Yusuf S, Mann JF. Eur J Prev Cardiol; 2014 Mar 22; 21(3):299-309. PubMed ID: 24191305 [Abstract] [Full Text] [Related]